Table 2

Maternal thyroid hormone levels of the three treatment groups during pre-pregnancy and G17
12 weeks of treatment (pre-pregnancy) G17
TSH (mIU/L) TT4(μg/dL) FT4(pmol/L) TSH (mIU/L) TT4(μg/dL) FT4(pmol/L)
LI 1.081 ± 0.27 * 1.15 ± 0.15 * 11.30 ± 0.70 * 0.120 ± 0.04 * 1.0 ± 0 *, a 9.51 ± 0.31 *
NI 0.063 ± 0.02 3.73 ± 0.41 25.10 ± 0.89 0.034 ± .000 2.66 ± 0.41 24.30 ± 2.77
3HI 0.029 ± 0.01 5.52 ± 0.95 * 29.23 ± 0.62 * 0.023 ± 0.01 3.95 ± 0.38 * 27.00 ± 3.34

Values are expressed as mean ± SEM; n = 6 for each group. *P <  0.05 compared with the NI control on the same day; aThe sensitivity of the chemiluminescence immunoassay for TT4 was 1.0 μg/dL.

Zhang et al.

Zhang et al. BMC Neuroscience 2012 13:121   doi:10.1186/1471-2202-13-121

Open Data